Lucid Diagnostics (LUCD) Share-based Compensation (QoQ) (2020 - 2026)
Lucid Diagnostics (LUCD) Share-based Compensation (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Lucid Diagnostics | 176.26 Mn | 142.85 Mn | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.06% |
| Mar 31, 2026 | -97.42% |
| Dec 31, 2025 | 1.13% |
| Sep 30, 2025 | 0.79% |
| Jun 30, 2025 | 10.97% |
| Mar 31, 2025 | -31.33% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | 2.25% |
| Jun 30, 2024 | 61.64% |
| Mar 31, 2024 | -22.85% |
| Dec 31, 2023 | -23.08% |
| Sep 30, 2023 | -10.51% |
| Jun 30, 2023 | -50.34% |
| Mar 31, 2023 | -19.24% |
| Dec 31, 2022 | -2.32% |
| Sep 30, 2022 | -7.10% |
| Jun 30, 2022 | 0.23% |
| Mar 31, 2022 | 7.91% |
| Dec 31, 2021 | 28.21% |
| Sep 30, 2021 | 7.44% |